abstract |
Rostafuroxin for use in treating or preventing a cardiovascular condition in an individual wherein said selected individual is carrying at least one polymorphism selected from the group consisting of rs2345088, rs16877182, rs16893522, rs246191 1, rs5013093, and rs12513375 sec for SEK, respectively : 11, ID BR SEK: 1, ID BR SEK: 9, ID BR SEK: 5, ID BR SEK: 3 and ID BR SEK: 7, and at least one selected genotype is from a group consisting of the TT genotype for rs2345088, heterozygous genotype C / T for rs16877182, genotype AA for rs16893522, genotype AA for rs246191 1, TT genotype for rs5013093, and TT genotype for rs12513375. The application contains 16 more claims. |